ABSTRACT The recovery of protein and two specific surfactant lipids, phosphatidylcholine and phosphatidylglycerol, from bronchoalveolar lavage fluid is altered in chronic and acute nongranulomatous interstitial lung disease. This study set out to determine whether the same is true for patients with sarcoidosis. The median value for recovery ofprotein from lavage fluid was significantly higher in 21 patients with sarcoidosis than in 19 normal subjects (18 v 11 mg), while the median value for phospholipid recovery was significantly lower (4 v 1-7 mg). There were no changes in the proportions of phosphatidylcholine and phosphatidylglycerol. In addition, significantly less of the neutral lipid, cholesterol, was recovered (3.2 v 1-5 mg). The combined values of three biochemical measurements, non-phospholipid polar lipid, non-polar lipid, and protein, correctly classified all 40 subjects in our series; in a further group of nine normal subjects and 11 patients with sarcoidosis it allowed all but one normal subject to be classified correctly. These results are discussed in terms of alterations in epithelial cell function in interstitial disease. 
Diffuse interstitial pulmonary disease is manifested by a range of abnormalities of the interstitium, which ultimately affect lung function with debilitating consequences. Analysis of cells and proteins recovered by bronchoalveolar lavage has proved useful in understanding the nature of the abnormalities that occur and in formulating critical questions regarding pathogenesis." Much less information is available on changes in lipid constituents of the alveolus, particularly those that relate to the function ofpulmonary surfactant.
Lipids generally are classified according to their chemical and physical properties rather than on a functional basis. Two major lipid groups are the uncharged neutral lipids, which include cholesterol and triglycerides, and charged or polar lipids, which include phospholipids. Phospholipids, because of the distribution of charge on their surface, are key components of cellular membranes. Certain phospholipids afso possess the unusual ability to lower surface tension at air-water interfaces. Thus they are key components of pulmonary surfactant, responsible for reducing alveolar surface tension. Two specific phospholipids, phosphatidylcholine and phosphatidylglycerol, are major determinants of surfactant activity.5 Other lipids, including non-polar lipids such as cholesterol, are also ofinterest because they may be expected to interdigitate with and thereby alter the surface active properties of surfactant.
Specific changes in the amount and proportion of phosphatidylcholine and phosphatidylglycerol recovered from bronchoalveolar lavage fluid have been reported in non-granulomatous interstitial lung disease.67 Studies of various animal models have led to the same conclusion and suggest that such measurements might be useful in understanding the alterations in lung function that occur.>" The purpose of the present study was to determine the degree to which similar changes also occur in a granulomatous disease, sarcoidosis. A Non-parametric tests were used because the data were non-normal. Mann-Whitney tests were used for comparison of median values between volunteers and patients with sarcoidosis, two sided comparisons being made in all cases.'8 Comparisons between radiographic type used the Kruskal-Wallis test for median values and multiple comparison procedures to adjust significance levels when simultaneous tests were made.'9 A log rank procedure for trend was used to determine whether a particular value increased or decreased when groups of patients were ordered with respect to radiographic type in the order type I, type II, type III.'"
In addition to these univariate analyses, stepwise discriminant analysis was used to examine the ability of groups of variables to distinguish collectively between patients and normal subjects.20 This procedure identifies the linear combination of variables showing the greatest difference between the two groups. The magnitude ofthe standardised coefficients associated with each variable in the linear function indicates their relative abilities to distinguish the two groups of subjects. The signs of the coefficients reveal the pattern of change that characterise patients with sarcoidosis. In this analysis we excluded one patient whose lavage protein concentration was more than 2000 mg/ml, because the stepwise discriminant analysis procedure is based on the assumption that the data are from a normally distributed population. The discriminant function we obtained consisted of the following variables, given with their standardised coefficients and in decreasing order of their contribution to the discriminant function: non-phospholipid polar lipid (1 053), protein (0 852), non-polar lipid (-0-241). This function correctly classified all 40 of the subjects in our study, high scores identifying patients with sarcoidosis. It also correctly classified all but one control subject when applied to a new group of nine normal subjects and patients (not shown), indicating that the variables selected and the equation used are not artefacts of the particular data set from which they were derived.
Discussion
The goal ofour studies was to determine what changes occur, if any, in lavage surfactant lipids in sarcoidosis. Several distinctive abnormalities were observed, reflecting a different pattern of change than that found in non-granulomatous interstitial disease. These abnormalities enabled us to distinguish patients with sarcoidosis from volunteers with a high degree of accuracy and were related to alterations in chest radiographs.
Our finding ofreduced phospholipid concentrations in our patients with sarcoidosis confirms an earlier report by Baughman et al,2' who studied 13 patients but did not provide data regarding the radiographic type of sarcoidosis. They also reported a change in the fatty acid composition of recovered phosphatidylcholine. Most of the phospholipid present in all samples was saturated phosphatidylcholine and phosphatidylglycerol. These phospholipids are major products of pulmonary type II epithelial cells.5 Thus our results suggest a reduced ability of these cells to synthesise or export (or both) surfactant constituents in sarcoidosis. Alternatively, there could be alterations in epithelial cell uptake mechanisms or other aspects of pulmonary clearance of these substances.2224 The degree to which these changes in phospholipidsF together with the fall in cholesterol, might affect physiological functions of the lung in terms of altered surfactant activity remains to be further explored.
Our finding of increased recovery of protein may relate to the lipid abnormalities. Our hypothesis is that this is due partly to injury or damage to the alveolar capillary membrane, leading to altered flux of serum proteins,25 since the vast majority of the protein is albumin, the proportion of which does not appear to be different from control values based on electrophoretic analysis (data not shown in results). Altered local production of immunoglobulins is also a likely contributor. Increased concentrations of proteins and other constituents might also be due to a defect in their clearance from the alveolar surface. Finally, protein could accumulate at the alveolar surface as a result of bronchiolar or airway damage. In any case, the lack of a correlation between protein and cell recovery for the patients with sarcoidosis, in contrast to that found in lavage fluid from normal subjects, suggests that whatever mechanism is responsible for the increase in lavage protein does not cause a similar change in the number of cells recovered in the lavage fluid.
Extracts The pattern of change in surfactant constituents that we observed for patients with sarcoidosis is quite different from that observed in non-granulomatous interstitial disease. Hallman et at reported a reduction in the proportion of phosphatidylglycerol relative to phosphatidylcholine in lavage fluid from patients with the adult respiratory distress syndrome. Our own preliminary studies of idiopathic pulmonary fibrosis documented by biopsy have produced similar data (mean PG/PC = 005 (SE 0.01), median = 0-04, n = 11; p < 0-05).7 Similar changes occur in acute lung injury induced by N-nitroso-N-methylurethane in dogs," and by oxygen89 and silica'0 in rats. These interesting changes may reflect a return of type II cell lipid metabolism to a pattern seen during fetal and postnatal lung development. 20 Our discriminant analysis indicates that three of the biochemical markers (non-phospholipid polar lipid, protein, and non-polar lipid) collectively have the ability to distinguish patients with sarcoidosis from normal subjects. Sarcoidosis patients were characterised by an increased proportion of non-phospholipid polar lipids or an increased protein concentration, or both, not accompanied by high concentrations of non-polar lipids. It was the proportion of polar lipids that were non-phospholipid, rather than the actual concentration, which distinguished the patients with sarcoidosis from the normal subjects. Further work, based on larger numbers, is necessary to refine the discriminant function and to determine its value in the clinical and research areas. In particular, it will be important to determine whether the biochemical markers can also differentiate different groups of patients from each other, as our own preliminary analyses suggest.7 In conclusion, our hypothesis is that measurement of change in cell function related to 932 protein permeability and lipid metabolism may be important in distinguishing granulomatous diseases such as sarcoidosis from other interstitial lung disorders. Many questions regarding the meaning of altered concentrations of surfactant constituents of lavage fluid in interstitial lung disease remain unresolved. Nonetheless, we believe that a fuller definition of the distinctive changes we and others have observed will lead to a better understanding of the pathogenesis of these diseases.
